A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
Titel:
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer
Auteur:
Aglietta, M. Barone, C. Sawyer, M.B. Moore, M.J. Miller Jr, W.H. BagalĂ , C. Colombi, F. Cagnazzo, C. Gioeni, L. Wang, E. Huang, B. Fly, K.D. Leone, F.